To The Moon

Log In/Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·12-22 07:11
      ARKG Investment Tracker position change: Increased position in Vertex Pharmaceuticals by 252 shares, the number of shares held increased 1.04% compared to the previous period and now represents 0.97% of the total position.
      366Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·12-22 07:11
      ARKG Investment Tracker position change: Increased position in Veracyte by 13,455 shares, the number of shares held increased 1.04% compared to the previous period and now represents 5.11% of the total position.
      46Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·12-22 07:11
      ARKG Investment Tracker position change: Increased position in Twist Bioscience Corp by 21,690 shares, the number of shares held increased 1.04% compared to the previous period and now represents 9.2% of the total position.
      22Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·12-22 07:11
      ARKG Investment Tracker position change: Increased position in Veeva by 657 shares, the number of shares held increased 1.04% compared to the previous period and now represents 1.39% of the total position.
      40Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·12-22 07:11
      ARKG Investment Tracker position change: Increased position in 10x Genomics, Inc. by 26,478 shares, the number of shares held increased 1.04% compared to the previous period and now represents 3.5% of the total position.
      5Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·12-22 07:11
      ARKG Investment Tracker position change: Increased position in Regeneron Pharmaceuticals by 126 shares, the number of shares held increased 1% compared to the previous period and now represents 0.9% of the total position.
      70Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·12-22 07:11
      ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 121,248 shares, the number of shares held increased 1.04% compared to the previous period and now represents 2.28% of the total position.
      5.80K2
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·12-22 07:11
      ARKG Investment Tracker position change: Increased position in Natera by 3,303 shares, the number of shares held increased 1.04% compared to the previous period and now represents 5.08% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·12-22 07:11
      ARKG Investment Tracker position change: Increased position in Illumina by 990 shares, the number of shares held increased 1.04% compared to the previous period and now represents 1.28% of the total position.
      14Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·12-22 07:11
      ARKG Investment Tracker position change: Increased position in Intellia Therapeutics by 28,476 shares, the number of shares held increased 1.04% compared to the previous period and now represents 3.34% of the total position.
      2Comment
      Report
       
       
       
       

      Most Discussed

       
       
       
       
       

      Terms and Conditions·Privacy Policy

      Company: TTMF Limited. Tech supported by Xiangshang Yixin.

      Email：uservice@ttm.financial